Douglas M. Lankler

Douglas M. Lankler is a declared insider of Pfizer Inc (senior executive), with filings sourced from SEC (Form 4). The record holds 11 filings, for trades running from 26 November 2021 to 25 February 2026.

No open-market purchase appears, only 2 sales worth €1.8M. Outside the open market, there are 2 share grants and 7 option exercises.

Most recently, on 27 February 2026, the filings show an option exercise worth €3.5M in Pfizer Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.